Zilico

About:

Zilico is focused on developing next generation cancer diagnostics to provide real-time diagnosis for cervical cancer.

Top Investors: Innovate UK, Deepbridge Capital, IP Group, SBRI Healthcare, Spark Ventures

Description:

Zilico is developing the next generation of cancer diagnostics that will provide real-time diagnosis for cervical cancer and reduce the inherent subjectivity of current methods. Two applications are under development: the first for the referral market and the second for the screening market.

Total Funding Amount:

$24.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Manchester, Manchester, United Kingdom

Founded Date:

2006-01-01

Contact Email:

info(AT)zilico.co.uk

Founders:

Brian Brown, John Tidy

Number of Employees:

11-50

Last Funding Date:

2019-05-01

IPO Status:

Private

Industries: